SCHEMBL3428702

SCHEMBL3428702

Nc1ccc2nc(NC3CCc4cc(F)ccc43)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.40
BACE1 P56817 2/20 0.38
PLAU P00749 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
TRPV1 Q8NER1 3/20 0.35
PFKFB3 Q16875 2/20 0.35
IDO1 P14902 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CASP6 P55212 1/20 0.35
MAPK14 Q16539 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3431332 0.91 BACE1 (0.38) HDAC6BACE1PLAUDDB1CRBN
SCHEMBL3405685 0.86 HDAC6 (0.40) HDAC6BACE1DDB1CRBNTRPV1
SCHEMBL3404143 0.84 FADS1 (0.43) HDAC6PLAUDDB1CRBNPFKFB3
SCHEMBL3401133 0.84 FADS1 (0.43) HDAC6PLAUDDB1CRBNPFKFB3
SCHEMBL3401635 0.81 HDAC6 (0.37) HDAC6DDB1CRBNMAPTCHRNB2
SCHEMBL3410874 0.81 DDB1 (0.37) BACE1PLAUDDB1CRBNKDM4E
SCHEMBL3431103 0.81 HDAC6 (0.39) HDAC6DDB1CRBNTRPV1PFKFB3
SCHEMBL4099205 0.80 TRPV1 (0.44) HDAC6TRPV1KDM4ELMNAPOLB
SCHEMBL4111676 0.79 HDAC6 (0.39) HDAC6TRPV1PFKFB3POLBTP53
SCHEMBL4108756 0.78 MAPT (0.43) HDAC6TRPV1PFKFB3KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US claimed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP claimed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO claimed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US claimed
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B HDAC6 884/4885BACE1 423/4885PLAU 3731/4885
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A HDAC6 2442/4885BACE1 3288/4885PLAU 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.